- βCGM significantly reduced HbA1c in insulin-treated Type 2 diabetes patients across 11 clinical trials
- βCGM users spent more time with blood sugar in the healthy target range compared to finger-stick testers
- βPatient satisfaction was consistently higher with CGM, and no serious device-related safety events were reported
| Journal | Cureus |
| Year | 2025 |
| Authors | Ali Badawi, Alhajri, Osman Altayb |
| PMID | 40918786 |
What Was Studied β and Why It Matters
For decades, people with Type 2 diabetes have managed their blood sugar using traditional finger-stick testing β a method that only captures a single snapshot in time. Researchers wanted to know whether real-time continuous glucose monitors (CGMs), which track blood sugar around the clock, actually lead to better health outcomes compared to conventional testing.
A 2025 systematic review published in Cureus analyzed 11 carefully designed clinical trials conducted between 2015 and 2025. The goal was straightforward: does wearing a CGM lead to measurably better blood sugar control in adults with Type 2 diabetes?
What the Research Found
The short answer is yes β especially if you use insulin. Here is what the evidence showed:
- Lower HbA1c levels: CGM users who take insulin saw meaningful reductions in their HbA1c, the 3-month average blood sugar measure that doctors use to assess long-term control.
- More time in range: CGM wearers spent significantly more hours with blood sugar in the healthy target zone β a major win for avoiding both highs and lows.
- Fewer dangerous swings: Even people with Type 2 diabetes who do not use insulin saw improved glycemic variability, meaning fewer unpredictable spikes and crashes throughout the day.
- Higher satisfaction: Across every study reviewed, patients using CGM reported greater satisfaction with their diabetes management than those using finger sticks.
- Safe to use: No serious device-related safety events were reported across all 11 trials.
One Important Nuance
The benefits were strongest when CGM was used consistently and paired with structured guidance from a healthcare provider. Occasional or unstructured use required multiple coaching sessions before patients saw lasting HbA1c improvements. In other words, having the device is just the first step β knowing how to act on the data is what drives results.
What This Means for Real Patients
If you are managing Type 2 diabetes β particularly with insulin β this research strongly supports asking your doctor about switching from finger-stick testing to a real-time CGM. The continuous data stream helps you and your care team spot patterns, adjust medications, and make smarter day-to-day decisions about food and activity.
Getting started is easier than many people expect. MDS Diabetes carries a wide range of CGM supplies and diabetes management tools, so you can find everything you need to begin monitoring continuously without the hassle of hunting across multiple providers.
The researchers also emphasize that personalized plans matter. Work with your healthcare provider to establish a routine that fits your lifestyle β because structured, consistent CGM use produced the greatest benefits in these trials.
Bottom Line
Real-time continuous glucose monitoring is a significant upgrade over traditional finger-stick testing for adults with Type 2 diabetes. It lowers HbA1c, keeps blood sugar in a healthy range more often, reduces dangerous fluctuations, and leaves patients feeling more in control of their health. The evidence is clearest for insulin users, but non-insulin users benefit too. Talk to your doctor about whether CGM is right for you β and when you are ready to get started, MDS Diabetes has the supplies to support your journey.